We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Synthetic Antiviral Proteins Inhibit SARS-CoV-2 in Lab-Grown Human Cells

News   Sep 10, 2020 | Original story from University of Washington

 
Synthetic Antiviral Proteins Inhibit SARS-CoV-2 in Lab-Grown Human Cells

An artists' conception of how small synthetic proteins, built from scratch from computer designs, can have an antiviral effect by binding with Spike proteins on SARS-CoV-2. The binding interferes with the infectivity mechanism of the virus to try to keep it from latching onto and entering cells. Credit: UW Medicine Institute for Protein Design

 
 
Advertisement
 

RELATED ARTICLES

On-the-Spot Coronavirus Test Within Spitting Distance

News

Mass testing that is fast, non-invasive and able to identify cases before people show symptoms holds the key to boosting COVID-19 detection, improving contact tracing and managing disease outbreaks.

READ MORE

More Turkey for Celiac Disease Sufferers?

News

People with celiac disease may find themselves more comfortable with extra Thanksgiving turkey. Researchers have found that tryptophan, an amino acid present in high amounts in turkey, combined with some probiotics, may help them heal and respond better to a gluten-free diet.

READ MORE

A Potential Target for Chemo-Resistant Cancer Cells

News

As researchers and medical professionals work to develop new treatments for cancer, they face a variety of challenges. One is intratumor heterogeneity -- the presence of multiple kinds of cancer cells within the same tumor. Often, these "mosaic" tumors include cells, such as polyploidal giant cancer cells, that have evolved to become aggressive and resistant to chemotherapy and radiation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE